A US-headquartered biopharmaceutical company focused on underserved neurological and rare disease communities, with two marketed products and a pipeline centered on neuropsychiatric symptoms in dementia-related conditions and neurodevelopmental disorders.
A US-headquartered biopharmaceutical company focused on underserved neurological and rare disease communities, with two marketed products and a pipeline centered on neuropsychiatric symptoms in dementia-related conditions and neurodevelopmental disorders.
